- Learning Objective 1: To educate the audience regarding the current status of adoptive cell therapy drug development.
- Learning Objective 2: To educate the audience regarding the fundamental principles of CAR T cell therapeutics.
- Learning Objective 3: Provide current data regarding activity of CAR T cells against children's cancers.
12/08/2022 - 12:00pm to 1:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Crystal Mackall, MD